期刊文献+

抗中性粒细胞浆抗体与肾小球肾炎 被引量:5

Antineutrophil Cytoplasmic Antibody and Glomerulonephritis
下载PDF
导出
摘要 目的 :研究抗中性粒细胞浆抗体 (antineutrophil cytoplasmic antibody,ANCA)与肾小球肾炎的关系。方法 :采用间接免疫荧光法及酶联免疫吸附法 ,对 48例各种类型的肾小球肾炎作血抗中性粒细胞浆抗体定性及定量测定 ,同时进行临床、病理、实验室检查对照。结果 :(1)在 48例肾小球肾炎患者中有 12例 ANCA阳性 ;(2 ) ANCA阳性患者的临床表现不尽相同 ;(3)在 ANCA阳性患者的肾小球内大多有新月体形成 ,血管病变及间质炎症 ;(4)ANCA阳性患者血中 TNF均高于正常值 ,在肾小球内的不同部位均可发现粘附因子 VCAM- 1沉积。结论 :一些肾小球肾炎实际上就是血管炎的一类 ,无论是病理变化 ,还是发病机理都有相同之处。 Objective:To study the relationship between antineutrophy cytoplasmic antibody and glomerulonephritis. Methods:Forty eight patients with glomerulonephritis verified by different histopathological features were investigated by indirect immunofluorescence and enzymelinked immunosorbent assays; besides,clinic,pathologic and lab examination were taken. Results:(1) 12/48 patients with glomerulonephritis were ANCA positive. (2) The clinical characteristics of ANCA positive patients differed. (3) There were crescent,vessel disease and interstitial inflammation in the glomeruli of ANCA positive petients. (4) Serum TNF of ANCA positive were higher than normal.The depositions of VCAM 1 in different parts of glomerulus were found. Conclusion:In fact,some glomerulonephritises were kinds of vasculitises.There are characteristics in common between them either in pathological varieties or in mechanism.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2000年第2期122-124,共3页 Journal of China Medical University
关键词 抗中性粒细胞浆 抗体 肾小球肾炎 ANCA antineutrophil cytoplasmic antibody small vessel vasculitis glomerulonephritis
  • 相关文献

参考文献3

二级参考文献3

  • 1杨敏,国外医学泌尿分册,1994年,14卷,58页
  • 2Lai K N,Clin Exp Immunol,1991年,85卷,396页
  • 3Zhao M H,Clin Exp Immunol,1995年,1卷,49页

共引文献16

同被引文献40

  • 1陈旻,于峰,张颖,赵明辉.426例抗中性粒细胞胞浆抗体相关性小血管炎患者多系统临床表现和肾脏病理分析[J].中华内科杂志,2005,44(11):828-831. 被引量:64
  • 2王湘玲,陈楠,俞海瑾,王伟铭,倪莉燕.阻断IgG-FcγR结合短肽在抗中性粒细胞胞浆抗体促进中性粒细胞凋亡中的作用[J].中华肾脏病杂志,2006,22(8):483-487. 被引量:6
  • 3梅洁卉,胡伟新,刘春蓓,张炯,陈惠萍,曾彩虹,刘志红,黎磊石.抗中性粒细胞胞浆抗体相关血管炎肾损害的临床病理分析[J].肾脏病与透析肾移植杂志,2007,16(2):127-133. 被引量:13
  • 4[1]Mark H. The merck manual of diagosis and therapy[M ].17th ed. Washington D. C Prentice Merck Inc, 1999. 301-305.
  • 5Alpa M,Ferrero B,Cavallo R,et al.Anti-GML and anfi-sulphatide anti-bodies in systemic idiophatic vasculitis,systemic lupus erythematosus and mixed cryoglobulinaemia:serum detection and clinical and electrophysiologic correlations[J].G Ital Nefrol,2002,19(6):617-621.
  • 6Reynolds WG,Stegenum CA,Cohen Tervaert JW,et al.463G/A myeloperoxidase promoter polymorphism is associated with clinical manifestation and the cource of disease in MPO-ANCA-associated vasculitis[J].Clin Immunol,2002,103(2):154-160.
  • 7Savige J,Gillis D,Benson E,et al.International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies(ANCA)[J].Am J Clin pathol,1999,111 (4):507-513.
  • 8Ludemann J.New aspects of human polymorphonuclear leukocytes[M].New York and London Plenum Prers,1993:141-150.
  • 9Sneller MC,Fanci AS.Pathogenesis of vasculitis syndromes[J].Med Clin N Am,1997,81(1):221-242.
  • 10Yang J J,Tutde RH,Hogan SL,et al.Target antigens for anti-neutrophil cytoplasmic antoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated nentrophils[J].Exper Immunol,2000,121 (1):165-172.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部